In contrast, no cleavage of caspase 3 was detected in treated T98G and U251MG malignant glioma cells, and there was no change in background levels of PARP cleavage noted in the 17α-AED-treated glioma cells as compared to glioma cells exposed to vehicle. Here, CASP3 is linked to central nervous system cancer.